Pneumocystis jirovecii pneumonia as a complication of etoposide therapy

Maria Alejandra Mendoza; Sunil Iyer; Jose F. Camargo; Pasquale W Benedetto

doi:10.1136/bcr-2021-242485

Pneumocystis jirovecii pneumonia as a complication of etoposide therapy

Maria Alejandra Mendoza, Sunil Iyer, Jose F. Camargo, Pasquale W Benedetto

Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Two patients receiving oral etoposide therapy developed Pneumocystis jirovecii pneumonia during chemotherapy with significant lymphopenia without corticosteroid use. In this commentary we discuss cellular mechanisms by which etoposide induced CD4+ T lymphocyte dysfunction and reduced survival may lead to predisposition to P. jirovecii infection.

Original language	English (US)
Article number	e242485
Journal	BMJ case reports
Volume	14
Issue number	6
DOIs	https://doi.org/10.1136/bcr-2021-242485
State	Published - Jun 10 2021

Keywords

haematology (incl blood transfusion)
infections
malignant disease and immunosuppression
pneumonia (infectious disease)

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1136/bcr-2021-242485

Cite this

@article{000533ba75ff4f1d982571dd4e0ea935,

title = "Pneumocystis jirovecii pneumonia as a complication of etoposide therapy",

abstract = "Two patients receiving oral etoposide therapy developed Pneumocystis jirovecii pneumonia during chemotherapy with significant lymphopenia without corticosteroid use. In this commentary we discuss cellular mechanisms by which etoposide induced CD4+ T lymphocyte dysfunction and reduced survival may lead to predisposition to P. jirovecii infection.",

keywords = "haematology (incl blood transfusion), infections, malignant disease and immunosuppression, pneumonia (infectious disease)",

author = "Mendoza, {Maria Alejandra} and Sunil Iyer and Camargo, {Jose F.} and Benedetto, {Pasquale W}",

year = "2021",

month = jun,

day = "10",

doi = "10.1136/bcr-2021-242485",

language = "English (US)",

volume = "14",

journal = "BMJ Case Reports",

issn = "1757-790X",

publisher = "BMJ Publishing Group",

number = "6",

}

TY - JOUR

T1 - Pneumocystis jirovecii pneumonia as a complication of etoposide therapy

AU - Mendoza, Maria Alejandra

AU - Iyer, Sunil

AU - Camargo, Jose F.

AU - Benedetto, Pasquale W

PY - 2021/6/10

Y1 - 2021/6/10

N2 - Two patients receiving oral etoposide therapy developed Pneumocystis jirovecii pneumonia during chemotherapy with significant lymphopenia without corticosteroid use. In this commentary we discuss cellular mechanisms by which etoposide induced CD4+ T lymphocyte dysfunction and reduced survival may lead to predisposition to P. jirovecii infection.

AB - Two patients receiving oral etoposide therapy developed Pneumocystis jirovecii pneumonia during chemotherapy with significant lymphopenia without corticosteroid use. In this commentary we discuss cellular mechanisms by which etoposide induced CD4+ T lymphocyte dysfunction and reduced survival may lead to predisposition to P. jirovecii infection.

KW - haematology (incl blood transfusion)

KW - infections

KW - malignant disease and immunosuppression

KW - pneumonia (infectious disease)

UR - http://www.scopus.com/inward/record.url?scp=85108007962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85108007962&partnerID=8YFLogxK

U2 - 10.1136/bcr-2021-242485

DO - 10.1136/bcr-2021-242485

M3 - Article

C2 - 34112634

AN - SCOPUS:85108007962

VL - 14

JO - BMJ Case Reports

JF - BMJ Case Reports

SN - 1757-790X

IS - 6

M1 - e242485

ER -

Pneumocystis jirovecii pneumonia as a complication of etoposide therapy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this